NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal…
Additional presentations will highlight the utility of Deep TMS™ in Smoking Addiction and OCDBURLINGTON, Mass. and JERUSALEM, May 04, 2022…
- VCN-11 incorporates a proprietary albumin binding domain in the virus shell with the potential to improve systemic delivery and…
– Data reconfirm previously highlighted safety and efficacy potential of AGTC-501 as a treatment for X-linked retinitis pigmentosa (XLRP) –…
BURBANK, CA, May 04, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biotech company…
J-Code, Effective July 1st, Will Enable a Streamlined Reimbursement Process for FYARRO™LOS ANGELES, May 04, 2022 (GLOBE NEWSWIRE) -- Aadi…
Campaign follows virtual Day on the Hill advocacy event asking government to #TakeActionForMSOTTAWA, May 04, 2022 (GLOBE NEWSWIRE) -- Each…
First Quarter Total Net Revenue of $36.1 Million Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., May 04, 2022…
Company’s upgraded medical delivery services available to its clients effective mid-May 2022TORONTO, May 04, 2022 (GLOBE NEWSWIRE) -- Entourage Health…
– Presented positive eight-month safety and efficacy data from ongoing DAVIO Phase 1 clinical trial for EYP-1901 in wet age-related…